Evoq Remedies Appoints Jay Pandya & Associates as Secretarial Auditor

Evoq Remedies Ltd has appointed M/s. Jay Pandya & Associates as its Secretarial Auditor for the financial year 2025-26. This decision was made during the Board of Directors meeting held on May 30, 2026. The board also approved the audited financial results for the half year and year ended March 31, 2026. However, the auditor's report expresses a qualified opinion with material uncertainty related to going concern, citing non-compliance with related party loan provisions, unconfirmed debtor and supplier balances, and unpaid tax liabilities.